Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction model-Reference-Cited by-同舟云学术

Nonlinear protein binding of phenytoin in clinical practice: Development and validation of a mechanistic prediction model

Published:2019-08-07 Issue:10 Volume:85 Page:2360-2368
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Heine Rob¹^ORCID,Kane Sean P.²,Huitema Alwin D.R.³,Krasowski Matthew D.⁴,Maarseveen Erik M.⁵

Affiliation:

1. Radboud institute for Health Sciences & Department of PharmacyRadboudumc Nijmegen The Netherlands

2. Department of Pharmacy PracticeRosalind Franklin University of Medicine and Science North Chicago IL USA

3. Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands & Department of Clinical Pharmacy, University Medical Center UtrechtUtrecht University Utrecht The Netherlands

4. Department of PathologyUniversity of Iowa Hospitals and Clinics Iowa City Iowa USA

5. Department of Clinical Pharmacy, Division of Laboratory Medicine and PharmacyUniversity Medical Center Utrecht, Utrecht University Utrecht The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14053

Reference26 articles.

1. Structure-activity relationships of phenytoin-like anticonvulsant drugs

2. Antiepileptic drugsbest practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies

3. Evidence‐based implementation of free phenytoin therapeutic drug monitoring;Burt M;Clin Chem,2000

4. The clinical pharmacokinetics of phenytoin

5. Interpatient and Intrapatient Variability in Phenytoin Protein Binding

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics and pharmacodynamic target attainment analysis of cefazolin using total and unbound serum concentration in patients with prostatectomy or nephrectomy;Antimicrobial Agents and Chemotherapy;2024-07-09

2. Facing the Facts of Altered Plasma Protein Binding: Do Current Models Correctly Predict Changes in Fraction Unbound in Special Populations?;Journal of Pharmaceutical Sciences;2024-06

3. Re‐discover the value of protein binding assessments in hepatic and renal impairment studies and its contributions in drug labels and dose decisions;Clinical and Translational Science;2024-05

4. Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug–Drug Interactions of Phenytoin;Pharmaceutics;2023-10-18

5. Population pharmacokinetics and pharmacodynamics of cefazolin using total and unbound serum concentrations in patients with high body weight;International Journal of Antimicrobial Agents;2023-04